Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.
Laupacis
Andreas
A
Institute for Clinical Evaluative Sciences, Toronto Ont. alaupacis@ices.on.ca
Paterson
J Michael
JM
Mamdani
Muhammad
M
Rostom
Alaa
A
Anderson
Geoffrey M
GM
D002170:Canada; D004341:Drug Evaluation / Q000592:standards / Q000639:trends*; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D019370:Observation / Q000379:methods; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D016032:Randomized Controlled Trials as Topic